D-Cysteinolic acid (1) analogues with an S-C-C-N skeleton showed increased platelet anti-aggregant activity in the following order: 2-aminoethanesulfonic acids, thiazolidines, 2-aminoethanethiols and 2-aminoethyl disulfides. Methyl substitutions at the 2-position potentiated the activity. Of these analogues, bis [(R)-2-aminopropyl] disulfide was the most potent inhibitor of platelet aggregation, with about 600-fold the activity of (1).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01950172 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review.
Purinergic Signal
December 2021
Graduate Program in Biomedical Sciences and Medicine Course, Federal University of Fronteira Sul - UFFS, Campus Chapecó, Rodovia SC 484 - Km 02, Fronteira Sul, 89815-899, Brazil.
In the last years, it has become evident that both acute and chronic physical exercise trigger responses/adaptations in the purinergic signaling and these adaptations can be considered one important mechanism related to the exercise benefits for health improvement. Purinergic system is composed of enzymes (ectonucleotidases), receptors (P1 and P2 families), and molecules (ATP, ADP, adenosine) that are able to activate these receptors. These components are widely distributed in almost all cell types, and they respond/act in a specific manner depending on the exercise types and/or intensities as well as the cell type (organ/tissue analyzed).
View Article and Find Full Text PDFPostoperative bleeding in essential thrombocytosis patients with colorectal cancer: Case report and literature review.
Int J Surg Case Rep
September 2021
Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Electronic address:
Introduction And Importance: Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by increased platelet count and a high risk of bleeding or thrombotic events due to platelet dysfunction. Patients with ET are treated according to their risk of complications with cytoreductive or anti-aggregant treatment. Neither guidelines for oncologic patients nor perioperative management of patients with ET have been determined.
View Article and Find Full Text PDFTicagrelor improves systemic immune-inflammation index in acute coronary syndrome patients.
Acta Cardiol
September 2022
Department of Cardiology, Pamukkale University, School of Medicine, Denizli, Turkey.
Objective: Inflammation plays a critical role in atherosclerosis. This study examines the effects of ticagrelor and clopidogrel on inflammatory parameters, obtained from complete blood count (CBC) and biochemical measurements, in patients with acute coronary syndrome.
Methods And Results: One hundred acute coronary syndrome (ACS) patients were included in the study and grouped according to clopidogrel ( = 50) or ticagrelor ( = 50) usage as an anti-aggregant (with acetylsalicylic acid).
Platelet Anti-Aggregant Activity and Bioactive Compounds of Ultrasound-Assisted Extracts from Whole and Seedless Tomato Pomace.
Foods
October 2020
Centro de Estudios en Alimentos Procesados (CEAP), CONICYT-Regional, Gore Maule, R09I2001, Talca 3460000, Chile.
Tomato paste production generates a residue known as tomato pomace, which corresponds to peels and seeds separated during tomato processing. Currently, there is an opportunity to use tomato pomace to obtain a functional extract with antithrombotic properties, such as platelet anti-aggregant activity. The aim of this study was to evaluate the yield and inhibitory activity of different extracts of tomato pomace on in vitro platelet aggregation, comparing this activity with commercial cardioprotective products, and quantify bioactive compounds.
View Article and Find Full Text PDFWhat are the risk factors of failure of enhanced recovery after right colectomy? Results of a prospective study on 140 consecutive cases.
Int J Colorectal Dis
July 2020
Department of Oncologic and Digestive Surgery of Hôpital Bicêtre, Université Paris Sud, 63, rue Gabriel Péri, 94270, Le Kremlin-Bicêtre, France.
Purpose: Nausea and vomiting is the main cause of failure of enhanced recovery protocol (ERP) after right hemicolectomy.
Methods: From January 2013 to January 2018, all patients undergoing right hemicolectomy were prospectively included. Patients undergoing emergency surgery, additional complex procedure or temporary stoma, nasogastric tube (NGT) maintenance, or abdominal drainage were excluded.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!